CAMBRIDGE, Mass. (September 10, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that its management is scheduled to present at the H.C. Wainwright 22nd Annual Global Investment Conference to be held virtually on September 14-16, 2020. Paul Gudonis, chief executive officer and David Henry, chief financial officer of Myomo will present a corporate overview of the Company on Tuesday, September 15, at 4:30 p.m. Eastern time. Read more.